HOME >> BIOLOGY >> NEWS
Receptor could be target for cancer therapy

Tumor cells have evolved a crafty scheme for protecting themselves from the killing power of the host immune system; in part, they disable the immune response.

New studies from a group of Vanderbilt University Medical Center investigators implicate a receptor for prostaglandin E2 (PGE2) in this phenomenon of tumor-induced immune suppression.

The findings, published in the March 1 Journal of Clinical Investigation, suggest that drugs that block the PGE2 receptor, called EP2, might restore the immune system's tumor-killing capacity.

"In two different transplantable tumor models in mice, it looks like the EP2 receptor is a key mediator of the tumor's immunosuppressive action," said Richard M. Breyer, Ph.D., associate professor of Medicine and Pharmacology.

The team of investigators, including Breyer, Dr. David P. Carbone, Ingram Professor of Cancer Research at the Vanderbilt-Ingram Cancer Center, and graduate student Li Yang, injected colon and lung cancer cells into two groups of mice -- normal mice and mice lacking the EP2 receptor (EP2 knockout mice). Tumors were smaller in the EP2 knockout mice, and these mice survived for longer periods of time compared to control mice.

"Not having an EP2 receptor appears to slow cancer growth and improve survivability," Breyer said. The researchers tracked the EP2 receptor effect to a difference in immune system function -- the EP2 knockout mice appeared to mount an effective tumor-killing immune response; the control mice did not.

Breyer's focus on the EP2 receptor stems from his long-standing interest in the biological effects of prostaglandins, a family of locally acting hormones produced by the cyclooxygenase (COX) enzymes. COX enzymes are the targets of aspirin and other non-steroidal anti-inflammatory drugs, which work to relieve pain and inflammation by blocking the production of prostaglandins.

The connection between COX and cancer was made in the early 1990s, Breyer said, when researc
'"/>

Contact: Clinton Colmenares
clinton.colmenares@vanderbilt.edu
615-322-4747
Vanderbilt University Medical Center
5-Mar-2003


Page: 1 2 3

Related biology news :

1. Receptor found that guides nerve cells to their final connecting sites
2. Receptor-dependent protein activation without a receptor
3. Researchers Engineer A Way To Improve T-Cell Receptors
4. Studies At Cedars-Sinai Confirm Identity Of An Elusive Receptor In Human Cells -- A Breakthrough In Understanding, Fighting Septic Shock
5. Scientists Discover Function For Type III TGF-Beta Receptor
6. Antiviral From Advanced Viral Research Corp. Inhibits CCR5 Cell Receptor For HIV
7. Allelix Clones Receptor For Intestinal Growth Factor GLP-2
8. Scientists Discover Key Cog In Receptor That Governs Ripening
9. UCSF/Gladstone Finding May Explain HIVS Ability To Infect Cells Lacking The Key Target Of HIV: The CD4 Receptor
10. Receptor May Increase Risk Of Urinary Tract Infections
11. New Findings On Receptor Regulation May Lead To Better Drugs For Diabetes

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/16/2019)... ... 2019 , ... HealthLink International, experts in the medical device ... facility on Friday, April 12. Headquartered in the Netherlands, HealthLink has been in ... square feet and houses 32 employees enabling HealthLink to be a total solutions ...
(Date:4/16/2019)... (PRWEB) , ... April 16, 2019 , ... ... Top 50 Healthcare Technology CEOs of 2019 . An extensive process was run ... of medical devices, biotech, healthcare analytics, healthcare software and other related areas. We ...
(Date:4/12/2019)... , ... April 11, 2019 , ... Neal O’Farrell is ... years of global experience. He is executive director of the consumer advocacy non-profit the ... students. Neal was a member of the Federal Communications Commission’s Cybersecurity Roundtable and is ...
Breaking Biology News(10 mins):
(Date:5/4/2019)... PINE BROOK, N.J. (PRWEB) , ... May 03, ... ... visual electrophysiology, announces the release of the Diopsys® ffERG/Photopic Negative Response ... signs of glaucoma. , By 2050, it is estimated that 6.3 million Americans ...
(Date:5/2/2019)... ... May 02, 2019 , ... Boston Robotic Hair ... area. Gone are the days of painful hair transplant procedures. Boston Robotic Hair ... is the only robotic intelligent solution to offer a minimally invasive procedure. With ...
(Date:4/16/2019)... , ... April 16, 2019 , ... ... systems, applications, and technology, today announced that Bank South Pacific (BSP), the largest ... RFP process. The bank awarded Fulcrum a contract to deliver a fingerprint-based Know ...
(Date:4/9/2019)... ... April 09, 2019 , ... USDM ... capacity of life sciences organizations to accelerate innovation and maximize productivity, announces that ... the past 12 months. , USDM’s Cloud Assurance is a managed ...
Breaking Biology Technology:
Cached News: